Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Posters by Code

Type your Poster Code, then hit apply

Showing 1,267 results.

Thumbnail for When Is Stopping Safe? Fixed-Duration Therapy and Treatment-Free Remission in Hematologic Malignancies: A Scoping Review

MM - 1654

When Is Stopping Safe? Fixed-Duration Therapy and Treatment-Free Remission in Hematologic Malignancies: A Scoping Review

Mansha Gupta

Poster Presenter: Mansha Gupta

Thumbnail for Superior 96-weeks MMR rates and safety with generic Dasatinib-50mg in newly diagnosed CML : Large Real-world multicentre study from India

CML - 1655

Superior 96-weeks MMR rates and safety with generic Dasatinib-50mg in newly diagnosed CML : Large Real-world multicentre study from India

Sujay Rainchwar

Poster Presenter: Sujay Rainchwar

Previous 1...131 132 133 134 135 136 137...141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Biomarkers Predicting Immune Effector Cell-Associated Neurotoxicity Syndrome After CAR-T Cell Therapy: A Systematic Review and Domain-Level Meta-Analysis

CT - 1656

Biomarkers Predicting Immune Effector Cell-Associated Neurotoxicity Syndrome After CAR-T Cell Therapy: A Systematic Review and Domain-Level Meta-Analysis

Felipe Soto

Poster Presenter: Felipe Soto

Thumbnail for Neurotoxicity across all FDA-approved CAR-T therapies: systematic comparison of pivotal trial and real-world data

CT - 1657

Neurotoxicity across all FDA-approved CAR-T therapies: systematic comparison of pivotal trial and real-world data

GURSHARAN KAUR

Poster Presenter: GURSHARAN KAUR

Thumbnail for Beyond a benign label: Mortality Trends Associated with Monoclonal Gammopathy of Undetermined Significance Among Adults Aged =45 Years in the United States, 1999-2024

MM - 1658

Beyond a benign label: Mortality Trends Associated with Monoclonal Gammopathy of Undetermined Significance Among Adults Aged =45 Years in the United States, 1999-2024

Fareed Baksh

Poster Presenter: Fareed Baksh

$Thumbnail for Prophylactic Tocilizumab During Bispecific Antibody Step-Up Dosing in Relapsed/Refractory Multiple Myeloma: CRS Mitigation, Low-Dose Strategies, and Outpatient Feasibility$

MM - 1659

Prophylactic Tocilizumab During Bispecific Antibody Step-Up Dosing in Relapsed/Refractory Multiple Myeloma: CRS Mitigation, Low-Dose Strategies, and Outpatient Feasibility

Valerin Arno Encarnacion

Poster Presenter: Valerin Arno Encarnacion

Thumbnail for Impact of Moderate-to-Severe Chronic Kidney Disease on Outcomes After CAR T-Cell Therapy in Multiple Myeloma: A Real-World Propensity Score-Matched Analysis

MM - 1660

Impact of Moderate-to-Severe Chronic Kidney Disease on Outcomes After CAR T-Cell Therapy in Multiple Myeloma: A Real-World Propensity Score-Matched Analysis

Mishaal Munir

Poster Presenter: Mishaal Munir

Thumbnail for Long-Term Risk of Clonal Evolution and Infectious Outcomes With Eltrombopag Plus Immunosuppressive Therapy in Idiopathic Aplastic Anemia: A Propensity-Matched Real-World Analysis

MDS - 1661

Long-Term Risk of Clonal Evolution and Infectious Outcomes With Eltrombopag Plus Immunosuppressive Therapy in Idiopathic Aplastic Anemia: A Propensity-Matched Real-World Analysis

Uchenna Amaechi

Poster Presenter: Uchenna Amaechi

Thumbnail for Racial Disparities in Outcomes Among Patients with NPM1-Mutated Acute Myeloid Leukemia: A Propensity Matched Real World Analysis

AML - 1662

Racial Disparities in Outcomes Among Patients with NPM1-Mutated Acute Myeloid Leukemia: A Propensity Matched Real World Analysis

Hema Hotchandani

Poster Presenter: Hema Hotchandani

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.